氟-18 市场概览、增长、趋势、分析、研究报告(2025-2031 年)

  • Report Code : TIPRE00038973
  • Category : Life Sciences
  • No. of Pages : 150
立即购买

[研究报告] 氟-18市场预测可以帮助该市场的利益相关者制定增长战略。预计该市场规模将从2024年的18.5亿美元增长到2031年的25.4亿美元;预计2025年至2031年期间的复合年增长率将达到4.7%。

市场洞察和分析师观点:

氟-18是一种用于医疗诊断程序的放射性同位素,也是全球最常用的医用放射性同位素之一。它具有良好的正电子发射特性,半衰期为109.8分钟。慢性病的高发病率和核成像技术的日益普及等因素推动了氟-18市场的增长。然而,氟-18的保质期较短阻碍了市场的增长。此外,放射性示踪剂在癌症诊断中的应用预计将在未来几年带来新的氟-18市场趋势。

增长动力:

核成像技术的广泛应用推动市场增长

先进的放射技术为诊断和核医学、放射治疗和介入放射学开辟了新天地。电离辐射在诊断和治疗中的应用使全球数百万患者受益。正电子发射断层扫描 (PET) 是临床环境中常用的核医学放射学检查方式,因为它有助于准确检测、定位和表征疾病。根据世界卫生组织 (WHO) 的数据,全球每年进行超过 36 亿次放射学诊断检查、3700 万次核医学程序和 750 万次放射治疗。根据欧盟委员会的数据,欧洲每年使用放射性药物和成像仪器进行约 1000 万次核医学程序,以诊断疾病并进行针对性治疗。这些技术也被应用于肿瘤学、免疫学、感染研究、胃肠病学、心脏病学、神经病学和精神病学。 PET/CT新型放射性药物的开发和上市,以及不同肿瘤分期方法的精准度不断提升,推动了氟-18市场的增长。例如,新推出的心脏放射性药物氟吡达唑F-18有助于更精确地对心血管疾病进行成像。

定制此报告以满足您的要求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

氟-18市场:

Fluorine-18 Market
  • 获取此报告的顶级关键市场趋势。
    此免费样品将包括数据分析,从市场趋势到估计和预测。

报告细分和范围:

氟-18市场分析考虑了以下细分领域:产品类型、应用和最终用户。根据产品类型,市场细分为FDG、NaF和其他。FDG细分市场在2022年占据了氟-18最大的市场份额,预计在预测期内将实现最高的复合年增长率。CAGR during the forecast period.

氟-18市场按应用分为肿瘤学、心脏病学、神经病学和其他领域。肿瘤学领域在2022年占据了最大的市场份额,预计在预测期内将实现最高的复合年增长率。CAGR during the forecast period.

按最终用户划分,市场分为医院、诊断中心和其他。2022年,医院占据了氟-18最大的市场份额。预计在预测期内,医院的复合年增长率最高。CAGR during the forecast period.

区域分析:

就地域而言,氟-18市场报告的范围包括北美、欧洲、亚太地区、南美和中美以及中东和非洲。2022年,北美占据了最大的市场份额。得益于混合成像等技术的进步、用于诊断和治疗的新型放射性药物的引入以及基于示踪原理的分子成像技术的发展,美国的核医学取得了显著增长。先进的医疗基础设施、目标疾病发病率和患病率的上升以及主要参与者的产品创新,进一步促进了北美氟-18市场规模的扩张。根据国际癌症研究机构(IARC)的数据,美国癌症病例预计将从2020年的228万例增加到2040年的312万例。此外,美国医疗保险和医疗补助服务中心(CMS)已根据《临床实验室改进修正案》(CLIA)采用了与人体实验室研究相关的标准,这有利于市场的发展。

行业发展和未来机遇:

以下列出了氟-18 市场主要参与者的一些战略发展:

  • 2023年10月,蓝地球诊断有限公司与中信医药集团就氟托福司他(18F)注射液(原名18F-rhPSMA-7.3)签署了独家战略协议。根据协议条款,两家公司将建立紧密的战略合作伙伴关系,共同为氟托福司他(18F)(一种PET显像剂)在中国前列腺癌​​患者中的分销提供技术和法规支持。此次协议的签署标志着蓝地球诊断公司致力于让全球患者和临床医生都能获得氟托福司他(18F)的战略迈出了重要一步。
  • 2023 年 7 月,欧盟委员会批准 Curium 公司生产的创新型 18F-PSMA PET 示踪剂 Pylclari 上市,用于在临床环境中使用 PET 检测前列腺癌成人患者的 PSMA 阳性(即前列腺特异性膜抗原)病变。
  • 2023年5月,蓝地球诊断公司(Blue Earth Diagnostics)获得美国食品药品监督管理局(FDA)批准其优化的高亲和力放射杂交(rh)PSMA靶向PET显像剂——POSLUMA(flotufolastat F 18)注射剂(以前称为18F-rhPSMA-7.3)。POSLUMA适用于通过PET检测前列腺癌患者的PSMA阳性病变,这些患者疑似转移或疑似复发(根据血清前列腺特异抗原(SA)水平升高)。转移性患者被视为初始确定性治疗的候选者。POSLUMA是首个也是唯一一个获得FDA批准的、采用专有rh技术开发的PSMA靶向显像剂。该显像剂于2023年6月通过蓝地球诊断公司全国放射性药物网络中的某些放射性药物进行商业化销售,该网络由其在美国的商业制造商和分销商组成。
  • 2021年5月,Lantheus Holdings, Inc. 获得FDA批准PYLARIFY,这是一种氟18标记的PSMA靶向PET显像剂,用于识别前列腺癌疑似转移或复发。PYLARIFY是首个也是唯一一个获得FDA批准的市售前列腺癌PSMA PET显像剂。

 

氟-18市场区域洞察

Insight Partners 的分析师已详尽阐述了预测期内影响氟-18 市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的氟-18 市场细分和地域分布。

Fluorine-18 Market
  • 获取氟-18市场的区域具体数据

氟-18市场报告范围

报告属性细节
2024年的市场规模18.5亿美元
2031年的市场规模25.4亿美元
全球复合年增长率(2025-2031)4.7%
史料2021-2023
预测期2025-2031
涵盖的领域按产品类型
  • 脱氧葡萄糖
  • 氟化钠
按应用
  • 肿瘤学
  • 心脏病学
  • 神经病学
按最终用户
  • 医院
  • 诊断中心
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 西门子医疗
  • 兰瑟斯医学成像公司
  • 诺华公司
  • 康德乐
  • 通用电气医疗集团
  • 欢欣鼓舞放射性药物
  • 礼来公司
  • 核子核技术研究工业有限公司
  • Curium制药公司

 

氟-18 市场参与者密度:了解其对业务动态的影响

氟-18市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求的驱动因素包括消费者偏好的转变、技术进步以及对产品优势的认知度的提升。随着需求的增长,企业正在扩展产品线,不断创新以满足消费者需求,并抓住新兴趋势,从而进一步推动市场增长。

市场参与者密度是指特定市场或行业内企业或公司的分布情况。它表明特定市场空间内竞争对手(市场参与者)的数量相对于其规模或总市值而言。

在氟-18 市场运营的主要公司有:

  1. 西门子医疗
  2. 兰瑟斯医学成像公司
  3. 诺华公司
  4. 康德乐
  5. 通用电气医疗集团

免责声明以上列出的公司没有按照任何特定顺序排列。


Fluorine-18 Market

 

  • 获取氟-18 市场顶级关键参与者概览

竞争格局和重点公司:

西门子医疗、Lantheus Medical Imaging Inc、诺华公司、康德乐、通用电气医疗、Jubilant Radiopharma、礼来公司、Nukleon 核技术研究工业有限公司、Curium Pharma 和 Blue Earth Diagnostics Inc 等公司是氟-18市场报告中介绍的知名公司。这些公司专注于开发新技术、升级现有产品并扩大其地域覆盖范围,以满足全球日益增长的消费者需求。

  • 历史分析(2 年)、基准年、预测(7 年)及复合年增长率
  • PEST 和 SWOT 分析
  • 市场规模价值/数量 - 全球、区域、国家
  • 行业和竞争格局
  • Excel 数据集
fluorine-18-market-report-deliverables-img1
fluorine-18-market-report-deliverables-img2
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

常见问题


What was the estimated fluorine-18 market size in 2024?

The fluorine-18 market was valued at US$ 1.85 billion in 2024.

What factors drive the fluorine-18 market?

Factors such as the high prevalence of chronic diseases and increasing use of nuclear imaging techniques propel the fluorine-18 market growth.

Who are the major players in the fluorine-18 market?

The fluorine-18 market majorly consists of the players, including Siemens Healthineers, Lantheus Medical Imaging Inc, Novartis AG, Cardinal Health, GE HealthCare, Jubilant Radiopharma, Eli Lilly and Company, Nukleon Nuclear Technology Research Ind Co Ltd, Curium Pharma, and Blue Earth Diagnostics Inc.

What is fluorine-18?

Fluorine-18 is a fluorine radioisotope used in medical diagnostic procedures and is among the most commonly used medical radioisotopes globally. Fluorine-18 has good positron-emitting properties and a half-life of 109.8 min.

What are the growth estimates for the fluorine-18 market till 2031?

The fluorine-18 market is expected to be valued at US$ 2.54 billion in 2031.

Which product type segment dominates the fluorine-18 market?

By product type, the fluorine-18 market is segmented into FDG, NaF, and others. The FDG segment held the largest fluorine-18 market share in 2025 and it is anticipated to register the highest CAGR during the forecast period.

Which end users segment dominates the fluorine-18 market?

The fluorine-18 market, by end users, is categorized into hospitals, diagnostic centers, and others. The hospitals segment held the largest market share in 2025 and is anticipated to register the highest CAGR during the forecast period.

Which application segment dominates the fluorine-18 market?

The fluorine-18 market, by application, is divided into oncology, cardiology, neurology, and others. The oncology segment held a larger market share in 2025 and is anticipated to register a higher CAGR during the forecast period.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies - Fluorine-18 Market

  1. Siemens Healthineers
  2. Lantheus Medical Imaging Inc
  3. Novartis AG
  4. Cardinal Health
  5. GE HealthCare
  6. Jubilant Radiopharma
  7. Eli Lilly and Company
  8. Nukleon Nuclear Technology Research Ind Co Ltd
  9. Curium Pharma
  10. Blue Earth Diagnostics Inc
fluorine-18-market-cagr

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.